The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency

Clinical trial NCT02020434 · COMPLETED

Trial details

NCT number: NCT02020434
Sponsor: Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Subjects With Varying Degrees of Renal Insufficiency and Subjects With Normal Renal Function

Start date: 2014-01-01
Primary completion: 2014-09-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.